Suspected side effects of GLP-1 medicines should be reported via the MHRA Yellow Card scheme (yellowcard
Although GLP-1RAs are generally well tolerated and considered safe drugs, as they gain widespread use for obesity, rare but serious adverse effects such as gastroparesis, bowel obstruction, pancreatitis and non-arteritic anterior ischemic optic neuropathy are emerging
GHRPs may offer a safer way to counteract age-related changes. Giustina & Veldhuis, Endocrine Reviews 7
Symptoms include abdominal pain, diarrhea, nausea, vomiting, fever and chills
Injectable options like Wegovy are available via specialist NHS weight management clinics, though waiting lists can be long